—— Globally Pioneering POGMENT Triple-Helix Biomimetic Collagen Debuts at Chinese Biomaterials Congress 2025
CHENGDU, China, Oct. 14, 2025 /PRNewswire/ — The 2025 Chinese Biomaterials Congress lately convened in Shaoxing, Zhejiang, bringing collectively a prestigious gathering of main minds in the sphere. Attendees included Chinese Academy of Engineering academicians Zhang Xingdong and Wang Yingjun, Chinese Academy of Sciences academicians Chen Xuesi, Tang Peifu, and Chen Chunying, alongside famend worldwide specialists similar to U.S. National Academy of Engineering member Leonard Pinchuk, UK Royal Society and Royal Academy of Engineering Fellow Molly Stevens, Professor Ki Dong Park (Fellow of the Korean Academy of Science and Technology and President of the 2024 World Biomaterials Congress), and Professor Kunio Ishikawa, President of the Japanese Society for Biomaterials. The meeting engaged in profound discussions on the frontiers and utility prospects of biomaterials.
LivingPhoenix Regenerative Technologies Development (Chengdu) Co., Ltd., acknowledged because the world’s first scientific innovation firm completely devoted to the analysis, improvement, and translation of triple-helix biomimetic collagen, was invited to the Congress. The firm systematically introduced its proprietary analysis achievements in triple-helix biomimetic collagen for the primary time, garnering important consideration from attending students, specialists, and business representatives.
At the session on Biomimetic and Life-Like Materials, Mr. Qin Xingjiong, Founder of LivingPhoenix® and Committee Member of the Rehabilitation Biomaterials Branch of the Chinese Society for Biomaterials, delivered a tutorial report titled “Safety and Efficacy Evaluation of a Chemically Synthesized Triple-Helix Biomimetic Collagen and Latest Research Progress.” The report detailed analysis collaboratively accomplished by his staff with Beijing Hospital, Peking University Third Hospital, the Ninth People’s Hospital of Shanghai Jiao Tong University School of Medicine, and The University of Tokyo, amongst different establishments. The research, with Professor Zhao Hongyi of Beijing Hospital and Professor Dong Jiying of Shanghai Ninth People’s Hospital serving as corresponding authors, featured Dr. Zhang Xinling of Beijing Hospital as the primary writer and Dr. Li Kexin of The University of Tokyo as a co-first writer. Contributors included Lu Nan, Dr. Takafumi Takebayashi, Dr. Zhou Boyu, and Xie Hongbin. The associated peer-reviewed paper was revealed in the SCI Q1 journal Frontiers in Bioengineering and Biotechnology in April 2025. The paper concluded that the biomimetic collagen element is protected, structurally secure, thermally secure, and demonstrates good biocompatibility and performance in each in vitro and in vivo experiments, with important potential for promotion and utility in regenerative biomedicine.
This achievement originates from basic analysis initiated in 2001 by Professor Masao Tanihara, Doctor of Engineering from Kyoto University, Japan. Developed in collaboration with the Nara Institute of Science and Technology, Kyoto University Faculty of Medicine, Kyoto Prefectural University of Medicine, and Nagoya University Graduate School, amongst others, the preliminary technological system was shaped over a decade, receiving national-level help from Japanese applications together with the “Knowledge Cluster Initiative” and “University Venture Creation Project.” In 2023, Dr. Takafumi Takebayashi, holder of the first-generation expertise, joined LivingPhoenix® with the related mental property. The firm concurrently established a core R&D staff led by Dr. Zhou Boyu of The University of Tokyo, fostering steady iteration and innovation by way of collaboration with Peking University, the Chinese Academy of Sciences, Shanghai Jiao Tong University, Naval Medical University, the University of Science and Technology of China, and the Tianfu Jincheng Laboratory (Frontier Medical Center). This effort achieved technological upgrades from model 1.0 to 2.0, ensuing in the grant of a number of invention patents and the submitting of a number of PCT worldwide patent functions.
According to an evaluation by Dr. Zheng Yongli, a Patent Attorney at Chengdu Gaoyuan Intellectual Property Agency, a search and evaluation of 240 international peer patents and their technical options confirmed that the Biomimetic Collagen Technology model 1.0 is globally pioneering and internationally main. Its model 2.0 additional enhances stability and self-assembly traits by way of the “Polymerization-Induced Self-Assembly (PISA) in water” course of. Notably, it represents the world’s first visualization of collagen fibrils utilizing 300 kV Cryo-Transmission Electron Microscopy to seize the ultrastructure of “collagen fibrils,” verifying the repeatability and consistency of self-assembled morphological options throughout a number of manufacturing batches, thus additionally possessing a “globally pioneering and internationally leading” attribute.
The product presently boasts a secure triple-helix construction and collagen fibrils, successfully addressing points frequent in commercially out there collagen merchandise, similar to brief length of impact and suboptimal organic performance. It additionally demonstrates a cost-leading benefit in its synthesis course of. Amid nationwide insurance policies encouraging the event of domestically pioneered, internationally main high-end medical gadgets, associated achievements have efficiently accomplished registration with the NMPA’s Medical Device Master File and submitting as a beauty ingredient. Among these, the injectable biomimetic collagen lyophilized fiber has handed the classification evaluate as a Class III medical machine. Subsequent product strains appropriate for useful cosmetics, medical dressings, fillers/implants, tissue engineering, and different utility situations are slated for gradual launch.
For collaboration alternatives in cosmetics, medical aesthetics, or high-end biomaterials, contact:
Email：[email protected]
Official web site：www.mylivingphoenix.com
View unique content material to obtain multimedia:https://www.prnewswire.com/news-releases/kyoto-university-engineering-phd-team-achieves-technology-transformation-in-chengdu-livingphoenixs-biomimetic-collagen-rated-international-leading-edge-302583352.html
SOURCE LivingPhoenix
